Harnessing the power of stem cell technology, we provide regenerative medicine to people who would have no other alternatives


Our technology addresses a global, unmet epidemic of degenerative diseases that are destroying the quality of life and longevity of millions worldwide. Three fourths of all healthcare expenditures are directly related to these diseases for which there are no cures. Our research, product development, manufacturing and human (clinical) trials are currently focused on five major medical categories: Cardiology; Neurology; Orthopedics; Ophthalmology, and Pulmonology. Find out more about how Stemedica's proprietary technology is making a difference.